Terms: = Lymphoma AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
85 results:
1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
2. Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study.
Jaccard A; Bridoux F; Roeloffzen W; Minnema MC; Bergantim R; Hájek R; João C; Cibeira MT; Palladini G; Schönland S; Merlini G; Milani P; Dimopoulos MA; Ravichandran S; Hegenbart U; Agis H; Gros B; Asra A; Magarotto V; Cheliotis G; Psarros G; Sonneveld P; Wechalekar A; Kastritis E
Clin Lymphoma Myeloma Leuk; 2024 May; 24(5):e205-e216. PubMed ID: 38453615
[TBL] [Abstract] [Full Text] [Related]
3. HLA-B*58 and HLA-B*27 Play a Role in the Development of Acute Leukemia: A Case Control Study.
Habour Nouar N; Yafour N; Youcef BY; Bouhass R; Chekkal M; Brahimi M; Bekadja MA; Sahraoui T
Asian Pac J Cancer Prev; 2024 Jan; 25(1):169-173. PubMed ID: 38285781
[TBL] [Abstract] [Full Text] [Related]
4. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution.
Messéant O; Drieux F; Sako N; Fataccioli V; Camus V; Robe C; Houot R; Tas P; Llamas-Gutierrez F; Lamaison C; Abraham J; Delage-Corre M; Benguerfi S; Bossard JB; Gaulard P; Lemonnier F
Eur J Cancer; 2024 Jan; 197():113479. PubMed ID: 38128263
[TBL] [Abstract] [Full Text] [Related]
5. EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas.
Turdo A; Gaggianesi M; D'Accardo C; Porcelli G; Bella SD; Cricchio D; Pillitteri I; Porcasi R; Lo Iacono M; Verona F; Modica C; Roozafzay N; Florena AM; Stassi G; Mancuso S; Todaro M
Front Immunol; 2023; 14():1266265. PubMed ID: 38035116
[TBL] [Abstract] [Full Text] [Related]
6. TCR Pathway Mutations in Mature T Cell lymphomas.
Zhang Y; Cheng K; Choi J
J Immunol; 2023 Nov; 211(10):1450-1458. PubMed ID: 37931208
[TBL] [Abstract] [Full Text] [Related]
7. Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Zhang C; Mou B; Xu J; Wang J; Liu Q; Yang Y; Tang W; Zhong X; Xu C
Br J Haematol; 2023 Dec; 203(5):807-819. PubMed ID: 37646306
[TBL] [Abstract] [Full Text] [Related]
8. Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry.
Burns EA; Wilson JJ; Mathur S; Kieser R; Gong Z; Hu CA; Tang CA; Petkova J; Yuen C; Mai H; Shah S; Rice L; Ganguly S; Pingali SR
Ann Hematol; 2023 Oct; 102(10):2753-2763. PubMed ID: 37422592
[TBL] [Abstract] [Full Text] [Related]
9. Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach.
Wang S; Deng Z; Wang Y; Bao W; Zhou S; Cui Z; Zheng D
BMC Nephrol; 2023 May; 24(1):146. PubMed ID: 37237260
[TBL] [Abstract] [Full Text] [Related]
10. Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study.
Bringhen S; Pour L; Benjamin R; Grosicki S; Min CK; C de Farias DL; Vorog A; Labotka RJ; Wang B; Cherepanov D; Cain LE; Manne S; Rajkumar SV; Dimopoulos MA
Clin Lymphoma Myeloma Leuk; 2023 Jul; 23(7):491-504. PubMed ID: 37149398
[TBL] [Abstract] [Full Text] [Related]
11. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Ruan J; Moskowitz A; Mehta-Shah N; Sokol L; Chen Z; Kotlov N; Nos G; Sorokina M; Maksimov V; Sboner A; Sigouros M; van Besien K; Horwitz S; Rutherford SC; Mulvey E; Revuelta MV; Xiang J; Alonso A; Melnick A; Elemento O; Inghirami G; Leonard JP; Cerchietti L; Martin P
Blood; 2023 May; 141(18):2194-2205. PubMed ID: 36796016
[TBL] [Abstract] [Full Text] [Related]
12. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.
Kameda T; Kataoka K; Kamiunten A; Hidaka M; Miyoshi H; Nakano N; Nosaka K; Yoshimitsu M; Yasunaga JI; Kogure Y; Shide K; Miyahara M; Sakamoto T; Akizuki K; Hidaka T; Kubuki Y; Koya J; Kawano N; Yamashita K; Kawano H; Toyama T; Maeda K; Marutsuka K; Imaizumi Y; Kato K; Sugio T; Tokunaga M; Tashiro Y; Takaori-Kondo A; Miyazaki Y; Akashi K; Ishitsuka K; Matsuoka M; Ohshima K; Watanabe T; Kitanaka A; Utsunomiya A; Ogawa S; Shimoda K
Haematologica; 2023 Aug; 108(8):2178-2191. PubMed ID: 36794502
[TBL] [Abstract] [Full Text] [Related]
13. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.
Gill H; Raghupathy R; Lee CYY; Yung Y; Chu HT; Ni MY; Xiao X; Flores FP; Yim R; Lee P; Chin L; Li VWK; Au L; Au WY; Ma ESK; Mohan D; Kumana CR; Kwong YL
BMC Cancer; 2023 Feb; 23(1):141. PubMed ID: 36765318
[TBL] [Abstract] [Full Text] [Related]
14. Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.
Burke GAA; Vinti L; Kabickova E; Beishuizen A; Tacyildiz N; Uyttebroeck A; Kang HJ; Luisi F; Minard-Colin V; Burkhardt B; Tamegnon M; Sun S; Curtis M; Deshpande S; Nottage K; Howes A; Srinivasan S; Bhojwani D; Norris R; Cairo M
Blood Adv; 2023 Feb; 7(4):602-610. PubMed ID: 36541957
[TBL] [Abstract] [Full Text] [Related]
15. Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell lymphoma.
Yoon SE; Cho J; Kim YJ; Kim SJ; Kim WS
Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):e972-e980. PubMed ID: 35995702
[TBL] [Abstract] [Full Text] [Related]
16. Clonal germinal center B cells function as a niche for T-cell lymphoma.
Fujisawa M; Nguyen TB; Abe Y; Suehara Y; Fukumoto K; Suma S; Makishima K; Kaneko C; Nguyen YTM; Usuki K; Narita K; Matsue K; Nakamura N; Ishikawa S; Miura F; Ito T; Suzuki A; Suzuki Y; Mizuno S; Takahashi S; Chiba S; Sakata-Yanagimoto M
Blood; 2022 Nov; 140(18):1937-1950. PubMed ID: 35921527
[TBL] [Abstract] [Full Text] [Related]
17. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract] [Full Text] [Related]
18. Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma.
Jain MD; Ziccheddu B; Coughlin CA; Faramand R; Griswold AJ; Reid KM; Menges M; Zhang Y; Cen L; Wang X; Hussaini M; Landgren O; Davila ML; Schatz JH; Locke FL; Maura F
Blood; 2022 Aug; 140(5):491-503. PubMed ID: 35476848
[TBL] [Abstract] [Full Text] [Related]
19. Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation.
Sala M; Allain N; Moreau M; Jabouille A; Henriet E; Abou-Hammoud A; Uguen A; Di-Tommaso S; Dourthe C; Raymond AA; Dupuy JW; Gerard E; Dugot-Senant N; Rousseau B; Merlio JP; Pham-Ledart A; Vergier B; Tartare-Deckert S; Moreau V; Saltel F
Oncogene; 2022 Apr; 41(18):2571-2586. PubMed ID: 35322197
[TBL] [Abstract] [Full Text] [Related]
20. Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell lymphomas.
Kim SJ; Kim YJ; Yoon SE; Ryu KJ; Park B; Park D; Cho D; Kim HY; Cho J; Ko YH; Park WY; Kim WS
Cancer Res Treat; 2023 Jan; 55(1):291-303. PubMed ID: 35240014
[TBL] [Abstract] [Full Text] [Related]
[Next]
